Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

polio

- PMLiVE

Non-antibiotic could ‘transform pneumonia therapy’

Lancet hails study as medical breakthrough

- PMLiVE

UK to add addiction warnings to opioids as use soars

Codeine-related deaths doubled in a decade

- PMLiVE

Time running out for ‘no-deal’ Brexit medicines laws

Needs parliament clearance before 29 March

- PMLiVE

As Brexit looms, UK medicines agency head Hudson announces departure

Search for successor must start in early 2019

- PMLiVE

MHRA cut out of regulatory work as Brexit looms

This year the regulatory body was only awarded two contracts to serve as the lead assessor on NDAs

To track disease, follow the money

Using paper currency to track infections sounds like a clever idea. But we think the smart money is on your phone.

Life Healthcare Communications

- PMLiVE

MHRA: No change for pre-Brexit products after UK exits the EU

And UK plans to follow EU rules for an implementation period after March 2019

- PMLiVE

MHRA joins Instagram as part of Yellow Card drive

UK medicines regulator follows in the footsteps of NICE in using the channel

Roche Basel Switzerland

UK is first to receive Roche’s rare lung cancer drug

Alecensa made available under MHRA's early access scheme

- PMLiVE

Gates Foundation agrees new polio funding deal

Expands its work with the Rotary Foundation and aims to raise up to $450m for the cause

MHRA launches medicines regulation blog as Brexit looms

MedRegs will provides insight into its latest regulatory thinking

- PMLiVE

J&J partner drive nets 15 new deals, and another NASH drug

Fosters new collaborations in treatment-resistant depression, infectious diseases and cancer

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links